Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.791 USD | -0.24% | -40.22% | -29.01% |
05-15 | Top Midday Decliners | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.01% | 30.23M | |
+10.04% | 115B | |
+11.97% | 106B | |
-2.59% | 21.96B | |
-12.41% | 21.87B | |
-5.29% | 19.21B | |
-4.03% | 18.08B | |
-38.57% | 17.71B | |
+7.02% | 14.32B | |
+35.06% | 12.42B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics : Guggenheim Starts Bolt Biotherapeutics at Buy With $42 Price Target